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NADPH Oxidase 4 Mediates Insulin-Stimulated HIF-1a
and VEGF Expression, and Angiogenesis In Vitro
Dan Meng1*, Aihong Mei2, Junxu Liu1, Xueling Kang1, Xianglin Shi3, Ruizhe Qian1, Sifeng Chen1
1 Department of Physiology and Pathophysiology, Fudan University Shanghai Medical College, Shanghai, China, 2 Department of Diagnosis, Shanghai Tenth People’s
Hospital, Tongji University School of Medicine, Shanghai, China, 3 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky, United States of America

Abstract
Acute intensive insulin therapy causes a transient worsening of diabetic retinopathy in type 1 diabetes patients and is
related to VEGF expression. Reactive oxygen species (ROS) have been shown to be involved in HIF-1a and VEGF expression
induced by insulin, but the role of specific ROS sources has not been fully elucidated. In this study we examined the role of
NADPH oxidase subunit 4 (Nox4) in insulin-stimulated HIF-1a and VEGF expression, and angiogenic responses in human
microvascular endothelial cells (HMVECs). Here we demonstrate that knockdown of Nox4 by siRNA reduced insulinstimulated ROS generation, the tyrosine phosphorylation of IR-b and IRS-1, but did not change the serine phosphorylation
of IRS-1. Nox4 gene silencing had a much greater inhibitory effect on insulin-induced AKT activation than ERK1/2 activation,
whereas it had little effect on the expression of the phosphatases such as MKP-1 and SHIP. Inhibition of Nox4 expression
inhibited the transcriptional activity of VEGF through HIF-1. Overexpression of wild-type Nox4 was sufficient to increase
VEGF transcriptional activity, and further enhanced insulin-stimulated the activation of VEGF. Downregulation of Nox4
expression decreased insulin-stimulated mRNA and protein expression of HIF-1a, but did not change the rate of HIF-1a
degradation. Inhibition of Nox4 impaired insulin-stimulated VEGF expression, cell migration, cell proliferation, and tube
formation in HMVECs. Our data indicate that Nox4-derived ROS are essential for HIF-1a-dependent VEGF expression, and
angiogenesis in vitro induced by insulin. Nox4 may be an attractive therapeutic target for diabetic retinopathy caused by
intensive insulin treatment.
Citation: Meng D, Mei A, Liu J, Kang X, Shi X, et al. (2012) NADPH Oxidase 4 Mediates Insulin-Stimulated HIF-1a and VEGF Expression, and Angiogenesis In
Vitro. PLoS ONE 7(10): e48393. doi:10.1371/journal.pone.0048393
Editor: Masuko Ushio-Fukai, University of Illinois at Chicago, United States of America
Received April 27, 2012; Accepted September 25, 2012; Published October 29, 2012
Copyright: ß 2012 Meng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Natural Science Foundation of China (81170298 and 30600245 to DM, 30830050 and 30771003 to SC), the
Shanghai Municipal Health Bureau Grant, c106629 (DM), and the National Basic Research Program of China 2009CB521900 (SC). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dmeng@fudan.edu.cn

muscle cells (VSMCs) [15–16]. There is evidence that the level of
Nox4 expression in endothelial cells in vivo is high as compared
with other Nox isoforms [17]. Nox4 is important for ROS
generation in human endothelial cells [18]. Moreover, Nox4
mediates endothelial responses to angiotensin-II [19], transforming growth factor-b [20] and epidermal growth factor [21], which
include migration and proliferation. These data suggest that Nox4
has a critical role in modulating endothelial cell physiology.
In this study we examined the role of Nox4 in insulin-stimulated
HIF-1a and VEGF expression, and angiogenic responses in
human microvascular endothelial cells (HMVECs). Here we
demonstrated that Nox4 mediates insulin-stimulated ROS generation, and angiogenesis in vitro, Nox4-derived ROS are essential
for HIF-1a-dependent VEGF expression induced by insulin.

Introduction
Acute intensive insulin therapy causes a transient worsening of
diabetic retinopathy with neovascularization in type 1 diabetes
patients and is related to VEGF expression [1]. Insulin-induced
VEGF expression has been reported to be mediated through the
activation of PI 3-kinase/AKT and p44/42 MAPK pathways, and
hypoxia-inducible factor-1a (HIF-1a) [2]. Insulin has been shown
to increase intracellular reactive oxygen species (ROS) production
in many cell types such as HepG2 cells [3], 3T3L1 adipocytes [4],
human fibroblasts [5], and retinal microvascular endothelial cells
[6]. ROS produced by insulin are involved in HIF-1a and VEGF
expression [3,7]. However, the specific ROS sources that mediate
insulin-induced HIF-1a and VEGF expression are not completely
defined.
ROS such as superoxide, hydrogen peroxide, and hydroxyl
radical are involved in the signaling pathways that mediate many
stress and growth responses, including angiogenesis [8–10]. Noxfamily NADPH oxidases have proven to be a major source of
ROS production in various cell types and have crucial roles in
various physiological and pathological processes [11–14]. We
showed previously that NADPH oxidase subunit 4 (Nox4)-derived
ROS generation in response to insulin-like growth factor-1 (IGF-I)
was linked to cell proliferation and migration in vascular smooth
PLOS ONE | www.plosone.org

Materials and Methods
Materials
Recombinant human insulin, diphenylene iodonium (DPI),
cyclohexamide (CHX), and antibody against b-actin were
purchased from Sigma-Aldrich (St. Louis, MO). 29,79-dichlorodihydrofluorescein diacetate (DCF-DA) was from Molecular Probes
(Eugene, OR). Antibodies against phospho-insulin receptor bsubunit (Tyr 1162/1163), insulin receptor b-subunit, phospho1
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Figure 1. Insulin increases ROS production through a Nox4-based NADPH oxidase in HMVECs. (A) Growth-arrested HMVECs were preincubated with DPI (5 mM) for 30 minutes, and then stimulated with insulin (100 nM) for 5 minutes. Measurement of ROS formation by DCF-DA
method was as described in Methods. (B) mRNA expression of Nox2 and Nox4 in HMVECs was determined by real-time RT-PCR. (C) HMVECs were
transfected with scrambled (control) or Nox4 siRNA. In 48 hours, the cells were harvested for detecting the Nox4 and Nox2 protein. (D) HMVECs were
transfected with control siRNA, Nox4 siRNA, or Nox2 siRNA. In 24 hours the cells were growth-arrested, followed by stimulation with insulin (100 nM)
for 5 minutes. ROS production was determined using DCF-DA as substrate. **P,0.01 vs. the control; ##P,0.01 vs. the insulin-treated group.
doi:10.1371/journal.pone.0048393.g001

at 488 nm with an emission at 540 nm. The fluorescence image
was collected by a single rapid scan with identical parameters for
all samples. Fluorescent levels were expressed as percent increase
over the control. The assays were carried out in duplicates, and
data were obtained from three independent experiments.

IRS-1(Tyr 1229), IRS-1, phospho-ERK1/2, ERK2, Nox4, Nox2,
MKP-1, SHIP-1, and human Nox4, Nox2 siRNA were from
Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against
phospho-AKT and AKT were from Cell Signaling (Beverly, MA).
Antibody against HIF-1a and Matrigel were purchased from BD
Pharmingen (San Diego, CA). For the detailed antibodies
information please see Table S1.

Small interfering RNA (siRNA) transfection
Non-silencing (control) siRNA (100 nM) or Nox4 siRNA
(100 nM) was transfected into HMVECs using the RNAi MAX
transfection reagent according to the manufacturer’s instructions
(Invitrogen). The non-silencing siRNA was used as a negative
control. 48 hours after transfection, the cells were starved for
16 hours followed by treatment with or without insulin.

Cell culture
Human microvascular endothelial cells (HMVECs) immortalized with the human telomerase catalytic protein (hTERT) [22]
were a kind gift from Dr. Rong Shao (University of Massachusetts,
Springfield, MA). The cells were cultured as described previously
[22].

Immunoblotting
Measurement of ROS

Immunoblotting was performed as described previously [15].

DCF-DA was used to measure ROS as described [16]. Growtharrested HMVECs were stimulated with 100 nM insulin for
5 minutes. After stimulation, HMVECs were incubated in
phosphate buffered saline (PBS) containing DCF-DA (5 mM) for
15 minutes in a light-protected humidified chamber at 37uC. Cells
were then rinsed in PBS and fixed with 10% buffered formalin.
Images were obtained with a LSM 510 laser scanning confocal
microscope (Carl Zeiss Inc., Thornwood, NY). The excitation was

PLOS ONE | www.plosone.org

Transient transfection and luciferase assay
Transient transfection and luciferase assay were performed as
described previously [23]. A 2.65 kb human VEGF gene promoter
in pGL2-basic luciferase reporter and a 46 bp human VEGF gene
promoter containing the HIF-1 binding site in pGL2-basic
luciferase reporter were kindly provided by Dr. Jiang (Thomas
Jefferson University, USA). The human wild-type Nox4 cDNA

2
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Figure 2. Nox4 is involved in insulin-stimulated insulin receptor and IRS tyrosine phosphorylation, ERK1/2, and AKT activation.
HMVECs were treated with Nox4 siRNA or scrambled control siRNA for 24 hours, and then incubated with serum-free medium for 16 hours. (A) The
tyrosine phosphorylated and total insulin receptor, (B) The tyrosine phosphorylated, the serine phosphorylated, and total IRS-1 protein levels were
measured after stimulation with 100 nM insulin for 5 minutes. (C) Phosphorylated and total ERK1/2, (D) phosphorylated and total AKT, and (E) SHIP-1,
MKP-1, Nox4, and b-actin protein expressions were determined after stimulation with 100 nM insulin for 30 minutes. Densitometry values (bottom)
were normalized as the indicated. *P,0.05, **P,0.01 vs. the control siRNA group; #P,0.05, ##P,0.01 vs. the insulin+control siRNA group.
doi:10.1371/journal.pone.0048393.g002

MLV) reverse transcriptase (Promega, Madison, WI). The primers
for human Nox4 were: 59-TGTTGGATGACTGGAAACCA-39
(forward), and 59-TGGGTCCACAACAGAAAACA-39 (reverse).
The primers for human Nox1 were: 59-GCCGACAAATACTACTACAC-39 (forward), and 59-GGACAGCAGATTGCGACA-39 (reverse). The primers for human Nox2 were: 59AAGATAGCGGTTGATGGG-39 (forward), and 59-TGAGAATGGATGCGAAGG-39 (reverse). The primers for human
Nox3 were: 59- CCTGGAAACACGGATGAG-39 (forward), and
59- CAGAAGAACACGCCAATAC-39 (reverse). The primers for
human Nox5 were: 59- ATTGCTCGCTATGAGTGGC-39
(forward), and 59-CCCTTGGACGACCTTTGA-39 (reverse).
The primers for human VEGF 165 were: 59-ATCTTCAAGCCATCCTGTGTGC-39 (forward), and 59-CAAGGCCCACAGGGATTTTC-39 (reverse). The primers for human HIF-1a
were: 59-CTCAAAGTCGGACAGCCTCA-39 (forward), and 59CCCTGCAGTAGGTTTCTGCT-39 (reverse). The primers for
human GAPDH are: 59- CCACCCATGGCAAATTCCATGGCA-39 (forward), and 59- TCTAGACGGCAGGTCAGGTCCACC-39 (reverse). Real-time PCR were performed
according to the methods described previously [16].

was cloned into the pcDNA3.1 vector. HMVECs were seeded in
12-well plates and cultured to 60–70% confluence. The cells were
transiently transfected with VEGF reporter or pGL2-basic
luciferase reporter and pCMV-b-galactosidase plasmid using
Lipofectamine 2000 from Invitrogen (Carlsbad, CA). The
transfected cells were cultured for 18–20 hours, and then
incubated in serum-free medium for 12 hours followed by the
incubation with insulin (100 nM) for 20 hours. Cells were lysed
with reporter lysis buffer. Luciferase (Luc) activities of the cell
extracts were determined using the Luciferase Assay System from
Promega (Madison, WI). b-Galactosidase (b-gal) activity was
measured. Relative Luc activity was calculated as the ratio of Luc/
b-gal activity, and expressed as the ratio of VEGF/pGL2-basic.
All luciferase assays reported here represent at least three
independent experiments, each consisting of three wells per
transfection.

Reverse transcription-PCR (RT-PCR) and real-time PCR
Total cellular RNA was isolated from HMVECs using Trizol
reagent (Invitrogen, Carlsbad, CA). 2 mg of RNA was processed
directly to cDNA with Moloney Murine Leukemia Virus (M-

PLOS ONE | www.plosone.org
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Figure 3. Nox4 mediates insulin-induced VEGF transcriptional activation through HIF-1. (A) HMVECs were co-transfected with a VEGF
reporter containing a 2.65-kb human VEGF promoter fragment or pGL2-basic luciferase reporter and b-gal plasmid. In 24 hours the cells were growtharrested, followed by stimulation with insulin (100 nM) for 24 hours in the presence or absence of DPI (5 mM). (B) VEGF reporter (2.65-kb) or (C) VEGF
reporter containing the HIF-1 binding site (46-bp) and b-gal plasmids were cotransfected with the control siRNA or Nox4 siRNA. In 24 hours, the cells
were growth-arrested and then treated with insulin (100 nM) for 24 hours. (D) VEGF reporter (2.65-kb) and b-gal plasmids were cotransfected with
Nox4 or pcDNA3.1 plasmid. In 24 hours, the cells were growth-arrested and then treated with insulin (100 nM) for 24 hours. Relative luciferase
activity was determined by the ratio of luciferase/b-galactosidase activity, and expressed as the ratio of VEGF/pGL2-basic. **P,0.01 vs. the control
siRNA group; ##P,0.01 vs. the insulin+control siRNA group.
doi:10.1371/journal.pone.0048393.g003

Quantification of VEGF protein

Cell proliferation assay

Human VEGF-A was quantified in the cell culture supernatant
using ELISA assay kit from R&D Systems, Inc. (Minneapolis,
MN). In brief, HMVECs were transfected with 100 nM Nox4
siRNA or control siRNA for 24 hours, the cells were growth
arrested and then treated with insulin (100 nM) for 24 hours. The
supernatants were collected, and total cellular protein was
measured by protein assay kit (Bio-Rad Laboratories, Hercules,
CA). VEGF-A production was expressed as pg/mg protein. The
assays were carried out in duplicates, represent three independent
experiments.

Cell proliferation was measured using a CCK-8 assay kit
(Dojindo, Japan) as described previously [25]. HMVECs were
transfected with the control or Nox4 siRNA for 24 hours, and
growth arrested for 16 hours. The cells were then seeded in 96well plate with insulin (100 nM) treatment for 24 hours. CCK-8
solution (150 ml) was added to each well followed by incubation for
2 hours. After incubation, the absorbance was measured at
450 nm using a microplate reader. The assays were measured in
sextuplicates, represent three independent experiments.

In vitro angiogenesis assay
Cell migration assay

In vitro endothelial cell tube formation assay in three dimensional Matrigel culture was used as a surrogate assay for
angiogenic potential. 200 ml of growth factor-reduced Matrigel
was preplaced in a 48-well plate. HMVECs were preincubated
with serum-free medium for 16 hours. The cells (1.56104) treated
with insulin (100 nM) were transferred onto 48-well Matrigel.
Endothelial tube formation was evaluated after incubation for
12 hours. The capillary-like tube structures were examined using
an inverted phase contrast microscope, and the tube formation
index was determined by measuring the average length of tubes in

Migration of HMVECs was determined by using transwell
chambers (24-well plates, 8-mm pore size, Corning, Inc.) as
described previously [24]. The top well was loaded with 16105
cells and insulin of 100 nM was added in the lower chamber to
induce chemotaxis. After 10 hours of incubation, the cells were
fixed and stained with 0.1% crystal violet. The number of cells
migrated to the bottom side was counted under a light microscope.
The assays were carried out in triplicates, represent three
independent experiments.
PLOS ONE | www.plosone.org
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Figure 4. Nox4 mediates insulin-induced HIF-1a mRNA and protein expression. HMVECs were transfected with Nox4 siRNA or the control
siRNA for 24 hours. The cells were growth arrested and then treated with 100 nM insulin for 12 hours. (A) HIF-1a mRNA levels were analyzed by real
time-PCR. (B) HIF-1a, PHD2, Nox4, and b-actin protein levels were determined by immunoblotting (*P,0.05, **P,0.01 vs. the control siRNA group;
#P,0.05, ##P,0.01 vs. the insulin+control siRNA group). (C) Cycloheximide (CHX) was added to a final concentration of 50 mg/ml, and the cells
were harvested after being incubated for the indicated time in the presence of CHX and insulin. HIF-1a, Nox4, and b-actin protein levels were
determined by immunoblotting (*P,0.05, **P,0.01 vs. zero-time control in insulin+con siRNA group; #P,0.05, ##P,0.01 vs. zero-time control in
insulin+Nox4 siRNA group).
doi:10.1371/journal.pone.0048393.g004

(Fig. 1A). Quantitative RT-PCR was performed to identify the
Nox isoforms of NADPH oxidase in HMVECs. Nox4 was highly
expressed in HMVECs, and the expression of Nox4 markedly
exceeded that of Nox2 (Fig. 1B), which is consistent with the
previous report [26]. Nox1 expression was detected at very low
level only (ct value of 37). Nox3 and Nox5 were undetectable in
HMVECs.
We next determined the role of Nox isoforms in insulinstimulated ROS production. None of Nox isoforms protein
expressions were changed by exposure to insulin for 5 minutes
or 2 days (data not shown). Considering the predominant
expressions of Nox4 and Nox2 in HMVECs, we used specific
siRNA-mediated gene silencing to modulate Nox4 or Nox2
expression. Transfection of Nox4 siRNA resulted in a 50%
decrease of Nox4 protein expression in HMVECs without
decreasing Nox2 expression (Fig. 1C). ROS generation by insulin
was significantly inhibited by Nox4 siRNA, whereas Nox2 siRNA
had no significant effect on insulin-induced ROS production
(Fig. 1D). These results show that insulin increases ROS
production via a Nox4-based NADPH oxidase in HMVECs.

five random fields from each well using an Axiovision software.
The assays were carried out in triplicates, represent three
independent experiments.

Statistical analysis
Data are expressed as mean6SE from three independent
experiments. Differences among groups were determined using
prism software with one-way analysis of variance followed by the
Newman-Keuls test, differences between two groups were assayed
by two-tailed student t-test. The 0.05 level of probability was used
as the criterion of significance.

Results
Insulin increases ROS production through a Nox4-based
NADPH oxidase
We measured ROS generation using DCF-DA, a membranepermeable dye that can be oxidized by intracellular ROS to the
fluorescent product 29,79-dichlorodihydrofluorescein (DCF). The
exposure of HMVECs to insulin (100 nM) for 5 minutes increased
intracellular ROS generation, the flavoenzyme inhibitor diphenylene iodonium (DPI) inhibited insulin-derived ROS generation

PLOS ONE | www.plosone.org
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Figure 5. Nox4 mediates insulin-induced VEGF mRNA and protein expression. HMVECs were transfected with Nox4 siRNA or the control
siRNA for 24 h. The cells were growth arrested and then treated with 100 nM insulin. (A) In 12 hours, VEGF 165 mRNA level was analyzed by real timePCR. (B) In 24 hours, the VEGF protein levels in the supernatants were determined by ELISA assay. *P,0.05, **P,0.01 vs. the control siRNA group;
#P,0.05, ##P,0.01 vs. the insulin+control siRNA group.
doi:10.1371/journal.pone.0048393.g005

is important for Nox4-mediated VEGF transcriptional activation,
a VEGF reporter containing a functional promoter fragment with
the HIF-1 binding site was used. Inhibition of Nox4 expression
also inhibited this VEGF reporter activity induced by insulin
(P,0.01, Fig. 3C), indicating that Nox4 mediates insulin-induced
VEGF transcription through HIF-1 activation. In addition,
overexpression of wild-type Nox4 enhanced the VEGF reporter
activity (Fig. 3D). Compared to cells transfected with the control
vector, insulin-stimulated VEGF transcriptional activation was
increased by 115% (P,0.01) in cells overexpressing wild-type
Nox4 (Fig. 3D).

Nox4 is involved in insulin-stimulated insulin receptor
and IRS tyrosine phosphorylation, ERK1/2, and AKT
activation
To explore the role of Nox4 in the insulin signaling pathway in
HMVECs, we measured tyrosine phosphorylation of the insulin
receptor and IRS-1. Insulin stimulated an increase in the tyrosine
phosphorylation of insulin receptor and IRS-1 in cells transfected
with the control siRNA. In cells transfected with the Nox4-specific
siRNA, however, insulin-stimulated insulin receptor b tyrosine
phosphorylation was decreased by 35% (P,0.01), and IRS-1
tyrosine phosphorylation was decreased by 32% (P,0.05)
compared to the control response (Fig. 2A and 2B). Importantly,
downregulation of Nox4 expression did not decrease the serine
phosphorylation of IRS-1 induced by insulin (Fig. 2B). We next
assessed the role of Nox4 in insulin-stimulated ERK1/2 and AKT
activation. As shown in Fig. 2C and 2D, insulin increased the
phosphorylation of ERK1/2 and AKT in cells transfected with the
control siRNA, whereas the activation of ERK1/2 and AKT by
insulin was significantly inhibited by Nox4 siRNA (P,0.05). As the
MAPK phosphatase-1 (MKP-1) mediates the dephosphorylation
and inactivation of ERK1/2 [27] and SHIP-1 (Src homology 2
domain–containing inositol 59-phosphatase 1) negatively regulates
the activation of AKT [28], we tested the effect of Nox4 silencing
on MKP-1 and SHIP-1 expression. Importantly, downregulation
of Nox4 had little effect on the expression of these phosphatases
including MKP-1 and SHIP-1 (Fig. 2E).

Nox4 mediates insulin-induced HIF-1a and VEGF mRNA
and protein expression
To determine whether Nox4 is involved in HIF-1a and VEGF
expression, the mRNA and protein levels of HIF-1a and VEGF
were measured in HMVECs transfected with Nox4-specific or
control siRNA. Insulin increased the mRNA and protein levels of
HIF-1a, which were inhibited by Nox4 siRNA (Fig. 4A and 4B).
To examine the molecular mechanism of HIF-1a protein
inhibition by Nox4 siRNA, we next investigated whether silencing
Nox4 alters the stability of HIF-1a. Cycloheximide (CHX), a
general inhibitor of protein synthesis, was used to prevent HIF-1a
de novo synthesis. HMVECs treated with CHX in combination
with insulin displayed a time-dependent decrease of HIF-1a
protein level (Fig. 4C). Knockdown of Nox4 expression did not
significantly change the rate of HIF-1a degradation (Fig. 4C).
Moreover, downregulation of Nox4 had little effect on HIF prolyl
hydroxylase domin 2 (PHD2) protein expression (Fig. 4B).
Similarly, Inhibition of Nox4 expression also inhibited insulininduced VEGF mRNA and protein expression (Fig. 5A and 5B).

Nox4 mediates insulin-induced VEGF transcriptional
activation through HIF-1
We investigated the potential involvement of Nox4 in the
transcriptional activation of VEGF induced by insulin in
HMVECs. HMVECs were transfected with a VEGF promoter
reporter containing a 2.65-kb human VEGF promoter. Inhibition
of ROS production by DPI or Nox4 siRNA inhibited insulininduced VEGF transcriptional activation (P,0.01, Fig. 3A and
3B). To test whether the HIF-1 binding site at the VEGF promoter
PLOS ONE | www.plosone.org

Nox4 mediates insulin-induced HMVEC migration,
proliferation and angiogenesis in vitro
To examine the role of Nox4 in insulin-induced HMVEC
migration, proliferation and angiogenesis in vitro, we knocked down
6
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Figure 6. Nox4 mediates insulin-induced HMVEC migration, proliferation, and angiogenesis in vitro. HMVECs were transfected with the
control or Nox4 siRNA for 24 hours. (A) The cells were growth arrested followed by stimulation with insulin (100 nM) for 10 hours. Cell migration was
measured as described in Methods. The data are expressed as the fold change relative to the control. (B) Growth-arrested cells were treated with
insulin (100 nM) for 24 hours. Cell proliferation was measured using CCK-8 assay as described in Methods. (C) and (D) HMVECs transfected with the
control or Nox4 siRNA were seeded onto Matrigel and incubated with or without insulin (100 nM), treated or not with H2O2 (0.1 mM) for 12 hours. The
relative tube lengths were normalized by the negative control. Bar = 1000 mm. **P,0.01 vs. the control siRNA group; #P,0.05, ##P,0.01 vs. the
insulin+control siRNA group.
doi:10.1371/journal.pone.0048393.g006

Nox4 using siRNA in HMVECs. We observed that inhibition of
Nox4 expression decreased insulin-induced cell migration
(P,0.05, Fig. 6A) and cell proliferation (P,0.05, Fig. 6B). The
functional effect of Nox4 on angiogenic potential was tested by
three dimensional Matrigel tube forming assays. The results
revealed that knockdown of Nox4 expression resulted in significant
inhibition of insulin-induced tube formation (P,0.01, Fig. 6C and
6D). Of note, compromise in Matrigel tube formation of Nox4
knockdown could be significantly corrected by administration of
exogenous H2O2 to cells (P,0.05, Fig. 6C and 6D).

In this study, we showed that insulin-induced ROS production
was reduced by the flavoenzyme inhibitor DPI or Nox4 siRNA,
but it was not affected by Nox2 siRNA (Fig. 1). These data suggest
that Nox4 is involved in the generation of ROS by insulin in
HMVECs. Similar findings were reported previously for insulin in
adipocytes [4,29]. Indeed, Nox4 is constitutively active and ROS
formation by Nox4 is linked to its expression [30–31]. We found
that a short (e.g. 5 minutes) exposure to insulin had no effect on
the expression of Nox4 or other Nox isoforms (data not shown),
but it enhanced ROS generation. It was known that Nox4/
p22phox complex formation is required for Nox4-derived ROS
[30]. Recent study has demonstrated that IGF-I stimulated Nox4/
p22phox complex formation within 5 minutes [32]. The exact
mechanism of acute insulin-induced ROS production still needs to
be identified.
We found that knockdown of Nox4 expression reduced the
tyrosine phosphorylation of IR-b and IRS-1, but did not change
the serine phosphorylation of IRS-1 in HMVECs (Fig. 2),
suggesting that insulin-stimulated tyrosine phosphorylation of

Discussion
Previous studies have shown that ROS are involved in insulin
signaling pathways [3,7]. However, the role of Nox4 in insulinstimulated HIF-1a and VEGF expression, and angiogenic
responses remains unknown. In this study, we provided evidence
that Nox4-derived ROS have an important role in activating
ERK1/2 and AKT, modulating HIF-1a-dependant VEGF
expression, and angiogenic responses induced by insulin.
PLOS ONE | www.plosone.org
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insulin receptor and its major receptor substrate is regulated by
Nox4. These findings are consistent with the previous observation
by Biswas and colleagues, which demonstrated that insulininduced Nox4-linked generation of ROS activated insulin receptor
tyrosine kinase by inhibiting protein-tyrosine phosphatase 1B
(PTP1B) in adipocytes [4]. Moreover, we found that inhibition of
Nox4 had little effect on the expression of the phosphatases such as
MKP-1 and SHIP. Our results are in contrast to that study in
human preadipocytes, which demonstrated that downregulation of
Nox4 attenuated MKP-1 expression, and promoted ERK1/2
activation and cell proliferation in response to insulin [33].
Differences between our findings and that study may be due to the
differences in the cells used. Furthermore, we found that Nox4
gene silencing had a much greater inhibitory effect on insulininduced AKT activation than ERK1/2 activation (Fig. 2C and
2D). It has been shown that PI3K/AKT pathway is essential for
retinal angiogenesis in the zebrafish [34]. Thus, our data suggest
that Nox4 plays a more important role in the PI3K/AKT pathway
than in the MAPK pathway for insulin signaling.
In this study, knockdown of Nox4 expression inhibited the
transcriptional activity of VEGF reporter containing the HIF-1
binding site, indicating that Nox4 mediates insulin-induced VEGF
transcription activation through HIF-1. Overexpression of Nox4
alone was sufficient to increase VEGF transcriptional activity, and
Nox4 enhanced insulin-stimulated the activation of VEGF (Fig. 3).
In addition, we also found that insulin-induced HIF-1a and VEGF
expression were blocked by PI3-kinase inhibitor LY294002 and
MEK1 inhibitor U0126 (data not shown). Thus, our findings
suggest that Nox4-derived ROS regulate insulin-induced HIF-1a
and VEGF expression through PI3K/AKT and ERK1/2
pathways.
Our findings demonstrated that insulin stimulated HIF-1 a
mRNA and protein expression. In deed, consistent with our
observation, it was recently demonstrated that insulin induced
HIF-1 a expression in mRNA and protein level in adipocytes [35].
Here, we showed that inhibition of Nox4 impaired insulinstimulated mRNA and protein expression of HIF-1a (Fig. 4A an
4B), suggesting that Nox4-derived ROS are required by insulin in
the stimulation of HIF-1a mRNA and protein expression.
Moreover, we found that knockdown of Nox4 expression did
not change the expression of PHD2 and the rate of HIF-1 a
degradation (Fig. 4B and 4C), indicating that HIF-1 a repression
by silencing Nox4 is not through the decrease of stabilization of
HIF-1 a protein. This is in line with the previous observation in
786-O renal carcinoma cells, which demonstrated that knockdown
of Nox4 by siRNA decreased HIF-2 a mRNA and protein levels

independent of pVHL, suggesting that Nox4-derived ROS
regulate HIF-2 a by a translational mechanism [36]. Similarly,
in the present study, Nox4 regulates the PI3K/AKT signaling,
which is important for the translation of HIF-1a protein
expression. Thus, it is likely that Nox4 mediates insulin-stimulated
HIF-1 a expression through a transcriptional and translational
mechanism in HMVECs. In the present study, we have
demonstrated that Nox4-derived ROS are essential for HIF-1adependent VEGF expression induced by insulin. In contrast to our
findings, a previous study showed that Nox3-derived ROS
regulated insulin-induced VEGF through the activation of Sp1,
but not by HIF-1a in HepG2 cells [37]. It suggests that insulinstimulated ROS modulate VEGF expression through multiple
pathways, depending on different Nox isoform involved.
We found that inhibition of Nox4 impaired insulin-stimulated
cell migration, cell proliferation, and tube formation in HMVECs,
and the impaired tube formation by knockdown of Nox4 can be
corrected by exogenous H2O2. These results support an
involvement of Nox4-derived ROS in insulin-induced angiogenesis in vitro. In fact, Nox4 has been associated with angiogenesis,
overexpression of Nox4 was sufficient to promote endothelial
proliferation, migration, and tube formation [6]. A recent study
has shown that Nox4 (2/2) mice exhibited attenuated angiogenesis, further confirming the important role of Nox4 in angiogenesis
[38].
In summary, the data presented here demonstrated that Nox4 is
a critical mediator of insulin-mediated ROS generation, HIF-1a
and VEGF expression, endothelial cell migration, and angiogenesis in vitro. Nox4 may be an attractive therapeutic target for
diabetic retinopathy caused by intensive insulin treatment.
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